Our data did not show significant differences in allele, genotype and haplotype frequencies between breast Pexidartinib cancer patients and healthy controls. In concordance with our study, Howell et al.[16], Smith et al. [17] and Balasubramanian et al.[18] reported that there were no apparent relationship of the IL-10 gene promoter polymorphisms with the risk of breast cancer. However, these results are not consistent with the study conducted in Austrian previously,

in which the -592AA genotype was shown to be associated with a reduced breast cancer risk[19]. Moreover, another study from the Italian buy FK228 population showed that the IL-10 -1082AA genotype was correlated with a marked increase in breast cancer risk[20]. Although it is difficult to determine the reasons behind the contradictory results in these studies, the different genetic background of study population may be one of the main factors. In this study, we found that the frequencies of the -1082 G,

-819 C and -592 C alleles among the healthy controls (0.061, 0.380 and 0.380, respectively) were similar to those observed in an Asian population[21, 22] but significantly lower than those of European Caucasians [23–25]. We also found that there was strong linkage disequilibrium among the -1082A/G, -819 T/C and -592 A/C polymorphisms. Complete linkage disequilibrium was observed between locus -819T/C and locus -592 A/C. Four possible haplotypes were demonstrated in our Thiazovivin population. Major haplotype frequency of the ATA among the controls in the present study was 0.585, which was significantly higher than those of study performed else in the European Caucasians (0.290 and 0.248, respectively)[24, 26]. These results suggest that the frequencies of IL-10 gene alleles and haplotypes might vary among the different ethnic population. Although we did not find an association of the IL-10 gene polymorphisms with risk of breast cancer, in present study we reported for the first time that the IL-10 promoter haplotypes and -1082 A/G polymorphism were significantly associated with the prognostic and predictive factors of breast cancer in

Chinese han women. Our data showed that the -1082AA genotype was associated with a significantly increased risk of lymph node (LN) involvement (P = 0.041) and larger tumor size (P = 0.039) at the time of diagnosis. Moreover, in the haplotype analysis of IL-10 gene, we also found that patients carrying ATA haplotype were in higher LN involvement (p = 0.022) and higher tumor stage(p = 0.028) of breast cancer at the time of diagnosis compared with others. The findings suggest that the IL-10 ATA haplotype and -1082AA genotype might be adverse prognostic factors in breast cancer in Chinese Han women. IL-10 is a multifunctional cytokine with both immunosuppressive and antiangiogenic functions, which may play varied roles in the pathogenesis and development of breast cancer.